Ashok Kumar Selected Research

poly-N-isopropylacrylamide

1/2016	Macrophage-derived reactive oxygen species protects against autoimmune priming with a defined polymeric adjuvant.
5/2015	Adjuvant poly(N-isopropylacrylamide) generates more efficient monoclonal antibodies against truncated recombinant histidine-rich protein2 of Plasmodium falciparum for malaria diagnosis.
8/2013	Characterization of chemically defined poly-N-isopropylacrylamide based copolymeric adjuvants.
11/2011	Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashok Kumar Research Topics

Disease

94	Neoplasms (Cancer) 03/2022 - 02/2002
65	Infections 06/2022 - 01/2002
50	Inflammation (Inflammations) 12/2021 - 01/2002
26	Wounds and Injuries (Trauma) 01/2022 - 09/2004
24	Endophthalmitis (Ophthalmia) 01/2022 - 01/2010
20	Body Weight (Weight, Body) 01/2020 - 09/2002
19	COVID-19 06/2022 - 10/2020
18	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 11/2003
17	Atrophy 12/2021 - 06/2007
16	Hypertension (High Blood Pressure) 01/2022 - 09/2002
16	Fibrosis (Cirrhosis) 01/2018 - 09/2006
15	Pain (Aches) 12/2021 - 11/2003
14	Disease Progression 01/2022 - 02/2003
14	Carcinogenesis 01/2021 - 11/2003
14	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 10/2018 - 03/2003
13	Cognitive Dysfunction 01/2021 - 08/2002
12	Necrosis 01/2022 - 02/2006
12	HIV Infections (HIV Infection) 11/2021 - 06/2002
12	Arthritis (Polyarthritis) 10/2021 - 07/2004
12	Gallbladder Neoplasms (Gallbladder Cancer) 02/2016 - 01/2007
12	Pathologic Constriction (Stenosis) 05/2013 - 07/2003
11	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2006
11	Rheumatoid Arthritis 01/2020 - 02/2007
10	Bacterial Infections (Bacterial Infection) 01/2022 - 11/2002
10	Sepsis (Septicemia) 01/2022 - 06/2007
10	Tuberculosis (Tuberculoses) 12/2021 - 02/2009
10	Essential Hypertension 10/2013 - 09/2002
9	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 10/2010
9	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 06/2003
9	Hepatocellular Carcinoma (Hepatoma) 12/2019 - 10/2005
8	Insulin Resistance 12/2019 - 06/2003
8	Colonic Neoplasms (Colon Cancer) 01/2018 - 03/2006
7	Thrombosis (Thrombus) 08/2022 - 06/2003
7	Squamous Cell Carcinoma of Head and Neck 03/2022 - 01/2016
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2012
7	Cachexia 01/2019 - 03/2010
7	Gallstones (Gallstone) 06/2014 - 02/2002
7	Pre-Eclampsia (Preeclampsia) 04/2014 - 06/2003
6	Neuroinflammatory Diseases 12/2021 - 01/2013
6	Hypoxia (Hypoxemia) 12/2021 - 04/2011
6	Muscular Diseases (Myopathy) 10/2021 - 02/2009
6	Obesity 06/2021 - 04/2016
6	Stroke (Strokes) 06/2020 - 06/2003
6	Osteoarthritis 01/2020 - 09/2013

Drug/Important Bio-Agent (IBA)

43	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2007
43	CytokinesIBA 12/2021 - 03/2003
36	Pharmaceutical PreparationsIBA 06/2022 - 08/2002
33	EnzymesIBA 04/2022 - 09/2005
31	Retinaldehyde (Retinal)IBA 09/2022 - 03/2006
21	AntioxidantsIBA 01/2022 - 06/2003
18	CryogelsIBA 01/2022 - 01/2005
18	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2007
15	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2003
15	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2006
15	NF-kappa B (NF-kB)IBA 12/2016 - 03/2003
14	Biological ProductsIBA 12/2020 - 11/2002
13	LipidsIBA 06/2022 - 01/2012
12	AntibodiesIBA 02/2022 - 01/2004
12	Immunoglobulin G (IgG)IBA 01/2022 - 01/2005
12	Transcription Factors (Transcription Factor)IBA 12/2021 - 09/2002
12	AngiotensinogenIBA 01/2019 - 09/2002
11	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2003
11	LigandsIBA 06/2020 - 09/2003
11	DystrophinIBA 10/2018 - 09/2006
10	AntigensIBA 06/2022 - 08/2003
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 03/2003
10	Interleukin-6 (Interleukin 6)IBA 10/2021 - 02/2006
10	Interleukin-10 (Interleukin 10)IBA 01/2021 - 06/2002
9	Immunoglobulin M (IgM)IBA 06/2022 - 09/2006
9	Oxygen (Dioxygen)IBA 01/2022 - 03/2008
8	VaccinesIBA 06/2022 - 01/2011
8	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2006
8	IronIBA 01/2022 - 01/2004
8	SphingolipidsIBA 01/2022 - 09/2012
8	Peptides (Polypeptides)IBA 10/2021 - 06/2005
8	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021 - 09/2012
8	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 01/2016
7	PolymersIBA 08/2022 - 01/2009
7	CalciumIBA 04/2022 - 08/2002
7	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2012
7	SteroidsIBA 01/2022 - 10/2007
7	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2010
7	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 07/2010
7	TNF Receptor-Associated Factor 6 (TRAF6)IBA 12/2017 - 12/2010
7	FlagellinIBA 11/2013 - 10/2007
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2010
6	CholesterolIBA 01/2022 - 10/2010
6	GoldIBA 01/2021 - 08/2010
6	InterleukinsIBA 04/2020 - 01/2006
6	Hormones (Hormone)IBA 01/2020 - 07/2007
6	CollagenIBA 01/2020 - 11/2008
6	Glutathione (Reduced Glutathione)IBA 01/2020 - 09/2002
6	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 02/2006
6	Superoxide DismutaseIBA 10/2018 - 04/2006

Therapy/Procedure

63	Therapeutics 01/2022 - 06/2003
12	Cholecystectomy 02/2018 - 02/2002
10	Drug Therapy (Chemotherapy) 01/2021 - 10/2010
8	Denervation 01/2021 - 03/2010
8	Intravitreal Injections 12/2020 - 04/2014
8	Oral Administration 11/2018 - 01/2005